GEA
VIVS

Glen Eagle Advisors’s VivoSim Labs VIVS Stock Holding History

Glen Eagle Advisors’s Portfolio VIVS Stock Details VIVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1
Closed -$6 – 1125
2024
Q4 		$6 Hold
1
– – ﹤0.01% 1105
2024
Q3 		$6 Hold
1
– – ﹤0.01% 1155
2024
Q2 		$9 Hold
1
– – ﹤0.01% 1137
2024
Q1 		$12 Hold
1
– – ﹤0.01% 1101
2023
Q4 		$13 Hold
1
– – ﹤0.01% 1038
2023
Q3 		$15 Hold
1
– – ﹤0.01% 1019
2023
Q2 		$21 Hold
1
– – ﹤0.01% 1058
2023
Q1 		$26 Hold
1
– – ﹤0.01% 1067
2022
Q4 		$17 Hold
1
– – ﹤0.01% 1147
2022
Q3 		$25 Hold
1
– – ﹤0.01% 1085
2022
Q2 		$21 Hold
1
– – ﹤0.01% 999
2022
Q1 		$45 Buy
+1
New +$42 ﹤0.01% 938

Other funds holding VIVS

PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
AFG
Albion Financial Group Salt Lake City, Utah $1.55B AUM 19.86% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Glen Eagle Advisors's VIVS Position: Q1 2025 in Review

Glen Eagle Advisors sold out of VivoSim Labs (VIVS) in Q1 2025, closing a stake of 1 share — an estimated $6 sold.

Glen Eagle Advisors first reported a position in VIVS in Q1 2022 and held it in 12 quarters. The position peaked at $45 in Q1 2022. 23 funds tracked by Wall St. Rank hold VIVS as of Q1 2025.

  • Glen Eagle Advisors reported no remaining VivoSim Labs position as of Q1 2025 after selling out during the quarter.
  • Glen Eagle Advisors sold 1 VivoSim Labs share in Q1 2025, an estimated $6.
  • Glen Eagle Advisors first reported a position in VivoSim Labs in Q1 2022 and held it in 12 quarters.
  • Glen Eagle Advisors's VivoSim Labs position peaked at $45 in Q1 2022.
  • 23 funds tracked by Wall St. Rank held VivoSim Labs as of Q1 2025.

Based on Glen Eagle Advisors's 13F filing for Q1 2025, filed 15 May 2025.